9H-Pyrido(3,4-b)indolium, 1,2,9-trimethyl- | 37689-97-7

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 哈马拉生物碱
• 英文名称: 9H-Pyrido(3,4-b)indolium, 1,2,9-trimethyl-
• 英文别名: 1,2,9-trimethylpyrido[3,4-b]indol-2-ium
• CAS: 37689-97-7
• 化学式: C14H15N2+
• 分子量: 211.28
• InChiKey: PTTHPPCERWUFON-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  16
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  8.8
• 氢给体数：
  0
• 氢受体数：
  0

文献信息

• HUMAN THERAPEUTIC AGENTS
  申请人：Life Plus, LLC

  公开号：US20160106724A1

  公开（公告）日：2016-04-21

  Human therapeutic treatment compositions comprise at least two of a curcumin component, a harmine component, and an isovanillin component, and preferably all three in combination. The agents are effective for the treatment of human conditions, especially human cancers.
• THERAPEUTIC COMPOSITIONS CONTAINING HARMINE AND ISOVANILLIN COMPONENTS, AND METHODS OF USE THEREOF
  申请人：Ions Pharmaceutical S.à r.l.

  公开号：US20170042866A1

  公开（公告）日：2017-02-16

  Human therapeutic treatment compositions comprise at least two of a curcumin component, a harmine component, and an isovanillin component, and preferably all three in combination. The agents are effective for the treatment of human conditions, especially human cancers.
• THERAPEUTIC COMPOSITIONS CONTAINING CURCUMIN, HARMINE, AND ISOVANILLIN COMPONENTS, AND METHODS OF USE THEREOF
  申请人：Ions Pharmaceutical S.à r.l.

  公开号：US20170042865A1

  公开（公告）日：2017-02-16

  Human therapeutic treatment compositions comprise at least two of a curcumin component, a harmine component, and an isovanillin component, and preferably all three in combination. The agents are effective for the treatment of human conditions, especially human cancers.
• US9402834B2
  申请人：——

  公开号：US9402834B2

  公开（公告）日：2016-08-02
• US9907786B2
  申请人：——

  公开号：US9907786B2

  公开（公告）日：2018-03-06